在HCC中,FCGR2A通过IL-4/JAK/STAT6轴促进M2巨细胞的两极分化
Shaojun Li1, Wanbo Shen2, Tingdong Yu2
1Hepatobiliary Pancreatic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, PR China; Hospital of Honghe State Affiliated to Kunming Medical University, Honghe, Yunnan, PR China.
Translational oncology
|June 7, 2025
概括
这项研究确定FCGR2A是肝细胞癌 (HCC) 发展的关键驱动因素. 在M2巨细胞中高FCGR2A表达促进瘤生长和免疫抑制,这表明肝癌的新治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是最常见的初级肝癌.
- 瘤微环境 (TME),特别是巨细胞,显著影响HCC的进展.
- 巨细胞在HCC发育中的确切作用仍然不完全理解.
研究的目的:
- 研究巨细胞在HCC发育中的作用.
- 为了确定特定的基因和途径参与巨细胞功能在HCC TME.
- 基于巨细胞活动,探索HCC的潜在治疗点.
主要方法:
- 单细胞测序以比较HCC和准癌症巨细胞中的基因表达.
- 在体内实验以验证基因和蛋白质表达水平.
- 功能性试验评估FCGR2A对巨细胞极化和HCC细胞增殖的影响.
- 对IL-4/JAK/STAT6信号通路的分析.
主要成果:
- 在HCC组织中,FCGR2A的表达很高,主要在M2巨细胞中.
- FCGR2A表达与晚期HCC阶段,转移和较差的生存结果 (OS和PFS) 相相关.
- FCGR2A通过IL-4分泌促进M2巨细胞的两极分化,激活IL-4/JAK/STAT6通路并增强HCC细胞的增殖.
- 表达FCGR2A的M2巨对NK和T细胞表现出免疫抑制作用.
结论:
- FCGR2A在HCC发育中发挥着至关重要的作用,通过驱动M2巨细胞两极分化,促进瘤生长和免疫逃避.
- FCGR2A/IL-4/JAK/STAT6轴代表了HCC的新型治疗目标.
- 向表达FCGR2A的巨细胞提供了HCC治疗的潜在策略.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
NF-κB-dependent Signaling Pathway
7.9K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.9K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Receptor Downregulation in MVBs
2.2K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.2K


